Personalised clinical studies have the potential to revolutionise the way clinical medicine is practised and clinical research is conducted. 

Personalised clinical studies involve methods called N-of-1 trials or single-case designs and can tell us which treatment works best for an individual. This is in contrast to traditional clinical trials, which tell us which treatments are effective on average. Personalised clinical studies can apply the rigour and principles of traditional clinical trials (e.g. blinding, randomisation) to tests of treatment and interventions in the individual. Personalised clinical studies can improve patient engagement in their own health. A series of personalised clinical studies can be aggregated to provide added value. 

N-of-1 Hub works with companies in the pharmaceutical, medtech, complementary medicine, digital health, and medicinal cannabis sectors to test their products using personalised clinical studies. N-of-1 Hub also works with universities, healthcare researchers, clinicians and CROs.